Literature DB >> 30723884

Bacteriostatic and Bactericidal Activities of Camel Lactoferrins Against Salmonella enterica Serovar Typhi.

Hussein A Almehdar1, Nawal Abd El-Baky2, Abdulqader A Alhaider1, Saud A Almuhaideb3, Abdullah A Alhaider4, Raed S Albiheyri1, Vladimir N Uversky5,6,7, Elrashdy M Redwan8,9.   

Abstract

Lactoferrin is an iron-binding glycoprotein present in various secretions (e.g., milk, tears, saliva, pancreatic juice), which performs multiple functions, with one of them being the antimicrobial defense. Purified camel lactoferrins (cLfs) from different Saudi camel clans, as well as human and bovine lactoferrins (hLf or bLf) were tested as antimicrobial agents against Salmonella enterica serovar Typhi (S. Typhi). All cLfs showed superior antibacterial potentials relative to hLf or bLf, while there was no noticeable difference in the antimicrobial capabilities between the cLfs from different camel clans. We observed synergy between the inhibitory activities of Lfs and antibiotics against bacterial growth. Expression of numerous bacterial proteins was affected by the treatment with Lf and its combinations, giving insight into the molecular mechanisms of the Lf action. Furthermore, several bacterial proteins were shown to interact with cLf-biotin. Scanning and transmission electron microscopy revealed the presence of obvious extracellular and intracellular changes after S. Typhi treatment by antibiotic (carbenicillin) or cLf alone, and in combination. The effects of antibiotics and Lf were synergistic, supporting the potential of the use of Lf-antibiotic combinations.

Entities:  

Keywords:  Antimicrobial; Bovine and human lactoferrins; Camel lactoferrin; Salmonella Typhi; Synergy

Mesh:

Substances:

Year:  2020        PMID: 30723884     DOI: 10.1007/s12602-019-9520-5

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   4.609


  38 in total

1.  The antibiotic resistance crisis: part 1: causes and threats.

Authors:  C Lee Ventola
Journal:  P T       Date:  2015-04

2.  Recombinant human lactoferrin: a valuable protein for pharmaceutical products and functional foods.

Authors:  Celia Conesa; Miguel Calvo; Lourdes Sánchez
Journal:  Biotechnol Adv       Date:  2010-07-17       Impact factor: 14.227

Review 3.  Potential lactoferrin activity against pathogenic viruses.

Authors:  Elrashdy M Redwan; Vladimir N Uversky; Esmail M El-Fakharany; Hussein Al-Mehdar
Journal:  C R Biol       Date:  2014-09-22       Impact factor: 1.583

4.  Identification, isolation, and partial characterization of a novel Streptococcus uberis adhesion molecule (SUAM).

Authors:  Raul A Almeida; Douglas A Luther; Hee-Myung Park; Stephen P Oliver
Journal:  Vet Microbiol       Date:  2006-03-27       Impact factor: 3.293

5.  Acoustic wave immunosensing of a meningococcal antigen using gold nanoparticle-enhanced mass sensitivity.

Authors:  Sreenivasulu B Reddy; David E Mainwaring; Mohammad Al Kobaisi; Panlop Zeephongsekul; John V Fecondo
Journal:  Biosens Bioelectron       Date:  2011-11-02       Impact factor: 10.618

6.  Tandem repeats of lactoferrin-derived anti-hepatitis C virus peptide enhance antiviral activity in cultured human hepatocytes.

Authors:  Ken-ichi Abe; Akito Nozaki; Kazushi Tamura; Masanori Ikeda; Kazuhito Naka; Hiromichi Dansako; Hiro-O Hoshino; Katsuaki Tanaka; Nobuyuki Kato
Journal:  Microbiol Immunol       Date:  2007       Impact factor: 1.955

Review 7.  Animal-derived pharmaceutical proteins.

Authors:  el-Rashdy M Redwan
Journal:  J Immunoassay Immunochem       Date:  2009

8.  Camel lactoferrin markedly inhibits hepatitis C virus genotype 4 infection of human peripheral blood leukocytes.

Authors:  El-Rashdy M Redwan; Ashraf Tabll
Journal:  J Immunoassay Immunochem       Date:  2007

9.  Structure and association of human lactoferrin peptides with Escherichia coli lipopolysaccharide.

Authors:  Daniel S Chapple; Rohanah Hussain; Christopher L Joannou; Robert E W Hancock; Edward Odell; Robert W Evans; Giuliano Siligardi
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

10.  Anti-infectivity of camel polyclonal antibodies against hepatitis C virus in Huh7.5 hepatoma.

Authors:  Esmail M El-Fakharany; Nawal Abedelbaky; Bakry M Haroun; Lourdes Sánchez; Nezar A Redwan; Elrashdy M Redwan
Journal:  Virol J       Date:  2012-09-16       Impact factor: 4.099

View more
  5 in total

1.  Synergistic Killing of Pathogenic Escherichia coli Using Camel Lactoferrin from Different Saudi Camel Clans and Various Antibiotics.

Authors:  Hussein A Almehdar; Nawal Abd El-Baky; Abdulqader A Alhaider; Saud A Almuhaideb; Abdullah A Alhaider; Raed S Albiheyri; Vladimir N Uversky; Elrashdy M Redwan
Journal:  Protein J       Date:  2019-08       Impact factor: 2.371

Review 2.  Research Development on Anti-Microbial and Antioxidant Properties of Camel Milk and Its Role as an Anti-Cancer and Anti-Hepatitis Agent.

Authors:  Muhammad Zahoor Khan; Jianxin Xiao; Yulin Ma; Jiaying Ma; Shuai Liu; Adnan Khan; Jamal Muhammad Khan; Zhijun Cao
Journal:  Antioxidants (Basel)       Date:  2021-05-17

3.  Effects of Pasteurization and High-Pressure Processing of Camel and Bovine Cheese Quality, and Proteolysis Contribution to Camel Cheese Softness.

Authors:  Mustapha Mbye; Huda Mohamed; Tholkappiyan Ramachandran; Fathalla Hamed; Ahlam AlHammadi; Rabih Kamleh; Afaf Kamal-Eldin
Journal:  Front Nutr       Date:  2021-06-17

4.  Determination of Lactoferrin in Camel Milk by Ultrahigh-Performance Liquid Chromatography-Tandem Mass Spectrometry Using an Isotope-Labeled Winged Peptide as Internal Standard.

Authors:  Xia Li; Zengmei Li; Enmin Xu; Ling Chen; Hua Feng; Lu Chen; Ligang Deng; Dongliang Guo
Journal:  Molecules       Date:  2019-11-19       Impact factor: 4.411

5.  Comparative Analysis of Milk Fat Globular Membrane (MFGM) Proteome between Saudi Arabia Camelus dromedary Safra and Wadha Breeds.

Authors:  Bassam H Sabha; Afshan Masood; Ibrahim O Alanazi; Assim A Alfadda; Hussein A Almehdar; Hicham Benabdelkamel; Elrashdy M Redwan
Journal:  Molecules       Date:  2020-05-04       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.